However, a recent study showed that mice lacking adipsin suppress the expansion of marrow adipose tissue (MAT), thereby inhibiting bone loss during obesity and aging [48], indicating that adipsin has a positive association with glucose-insulin homeostasis but has a negative association with bone remodeling. Here, INS is linked to obesity disorder.